David
Middle Name
Samuel
Mathai
Middle Name
Samuel
Picture
David
Middle Name
Samuel
Mathai
Middle Name
Samuel
Resident Physician
Positions
- Resident Physician
-
The Menninger Department of Psychiatry and Behavioral Sciences
Baylor College of Medicine
Houston, TX
Education
- MD from Baylor College of Medicine
- 05/2017 - Houston
- BS from Texas AandM University
- 12/2012 - College Station
- Biochemistry, Genetics
Honors & Awards
- Hilde Bruch Award for Excellence in Psychiatry
- Baylor College of Medicine
- AAAP Travel Award
- The American Academy of Addiction Psychiatry (01/2016 - 12/2016)
- J.K. Alexander Travel Award
- Baylor College of Medicine (01/2015 - 12/2015)
- APA Research Colloquium Junior Investigator Award
- American Psychiatric Association
- Robert and Sara Jane White Scholarship
- American Group Psychotherapy Association
- Stacia Micheletto Award in Psychodynamic Psychiatry
Professional Interests
- Psychodynamic psychotherapy
- Trauma recovery
- Psychedelic medicine
- Therapeutic ketamine
- Ethics in psychiatry
Selected Publications
- ""Just One Bad High:" Considering Synthetic Cannabinoid Outcome Expectancies in Adolescents." :
- "Paradoxical increase in synthetic cannabinoid emergency-related presentations after city wide ban: Lessons from Houston, Texas." :
- "Ketamine and other glutamate agents." 2017 May ; :
- "Childhood maltreatment and posttraumatic stress disorder." :
- "Borderline personality disorder and a spectrum of trauma." :
- "Persistent and long-term neuropsychiatric implications of cannabis use in adolescents." AJP Resident's Journal. 2017 June ; :
- "Guanfacine attenuates adverse effects of dronabinol (THC) on working memory in adolescent-onset heavy cannabis users: a pilot study." :
- "Revisiting the hallucinogenic potential of ketamine." :
- "Recovery from impaired working memory performance during chronic Δ-9-tetrahydrocannabinol administration to adolescent rhesus monkeys." :
- "The relationship between subjective effects induced by a single dose of ketamine and treatment response in patients with major depressive disorder: A systematic review." :
- "Use of guanfacine for cannabis use disorder and related symptomatology." :
- "S100 inhibitors – A new paradigm for treating Alzheimer’s disease." :
Memberships
- The American Academy of Addiction Psychiatry
- Society of Biological Psychiatry
- American Group Psychotherapy Association
Log In to edit your profile
